HSP90 also contributes to the regulation of PI3 K/AKT signaling, which is involved in melanoma cell proliferation, migration and survival [57, 58], and it is often activated in melanoma cells resistant to BRAF and MEK inhibitors [59]. This evidence concerns the gene AKT1 and melanoma.